PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086222
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086222
Methicillin-resistant staphylococcus aureus (MRSA) is an infection of the skin that occurs mostly in hospitals and healthcare facilities. It is treated with commonly used antibiotics and usually spreads from person to person by direct skin-to-skin contact. Physicians often find MRSA harder to treat than most other strains of staphylococcus aureus because it is sometimes resistant to commonly-used antibiotics such as methicillin. Some of the most commonly used antibiotics use for the treatment of MRSA include glycopeptides and lipoglycopeptides, oxazolidinones, lipopeptides, cephalosporin, and others. These drugs are used to kill or restrain Methicillin-resistant staphylococcus aureus infection.
Rising number of pipeline products, and increasing product launches & approval for the treatment of MRSA infection are some of the major factors responsible for the growth of global Methicillin-resistant staphylococcus aureus (MRSA) market. For instance, For instance, in 2018, Destiny Pharma received investigational new drug application from FDA for its new candidate, XF-73, a dicationic porphyrin molecule based nasal gel, to combat post-surgical infections of Methicillin-resistant Staphylococcus aureus (MRSA).
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country:
? U.S.
? Canada
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country:
? Brazil
? Mexico
? Argentina
? Rest of Latin America
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country:
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country:
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of Asia Pacific
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country:
? GCC
? Israel
? Rest of Middle East
? By Drug Class:
? Glycopeptides and Lipoglycopeptides
? Oxazolidinones
? Lipopeptides
? Cephalosporin
? Tetracycline
? Others
? By Distribution Channel:
? Hospital Pharmacies
? Retail Pharmacies
? Online Pharmacies
? By Country/Region:
? South Africa
? Central Africa
? North Africa
? Company Overview
? Material Portfolio
? Financial Performance
? Key Highlights
? Market Strategies
"*" marked represents similar segmentation in other categories in the respective section.